Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $17.08 HKD
Change Today -0.20 / -1.16%
Volume 318.0K
As of 4:01 AM 05/27/15 All times are local (Market data is delayed by at least 15 minutes).

shandong luoxin pharmaceut-h (8058) Snapshot

Open
$17.28
Previous Close
$17.28
Day High
$17.28
Day Low
$16.80
52 Week High
11/14/14 - $18.38
52 Week Low
07/21/14 - $10.06
Market Cap
10.4B
Average Volume 10 Days
424.0K
EPS TTM
$0.71
Shares Outstanding
164.6M
EX-Date
06/10/15
P/E TM
19.4x
Dividend
$0.30
Dividend Yield
2.18%
Current Stock Chart for SHANDONG LUOXIN PHARMACEUT-H (8058)

Related News

No related news articles were found.

shandong luoxin pharmaceut-h (8058) Related Businessweek News

No Related Businessweek News Found

shandong luoxin pharmaceut-h (8058) Details

Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. engages in the manufacture and sale of pharmaceutical products in the People’s Republic of China. It is also involved in the manufacture and wholesale of biochemical products and Chinese medicine. The company was formerly known as Shandong Luoxin Pharmacy Stock Co., Ltd. and changed its name to Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. in August 2014. The company was founded in 1995 and is based in Linyi, the People’s Republic of China. Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. is a subsidiary of Shandong Luoxin Holdings Co., Ltd.

Founded in 1995

shandong luoxin pharmaceut-h (8058) Top Compensated Officers

Chief Executive Officer, Head of Research & D...
Total Annual Compensation: CNY120.0K
Executive Director
Total Annual Compensation: CNY48.0K
Secretary of the Board and Executive Director
Total Annual Compensation: CNY60.0K
Vice General Manager of Production Department...
Total Annual Compensation: CNY60.0K
Manager of Bulk Medicine Workshop and Supervi...
Total Annual Compensation: CNY60.0K
Compensation as of Fiscal Year 2013.

shandong luoxin pharmaceut-h (8058) Key Developments

Shandong Luoxin Pharmacy Stock Co. Ltd. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015

Shandong Luoxin Pharmacy Stock Co. Ltd. reported unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, turnover was RMB 776,364,000 against RMB 643,330,000 a year ago. Profit before taxation was RMB 127,108,000 against RMB 149,256,000 a year ago. Profit attributable to owners of the company was RMB 108,209,000 or 17.76 cents per basic and diluted share against RMB 121,937,000 or 20.00 cents per basic and diluted share a year ago. The increase in turnover was attributable to the Group's launch of products with high added-values, an upgrade of the Group's product portfolio and the acceleration of sales network development to increase the market share of its products.

Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. to Report Q1, 2015 Results on May 06, 2015

Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. announced that they will report Q1, 2015 results on May 06, 2015

Shandong Luoxin Pharmaceutical Group Stock Co., Ltd., Board Meeting, May 06, 2015

Shandong Luoxin Pharmaceutical Group Stock Co., Ltd., Board Meeting, May 06, 2015., at 10:00 China Standard Time. Agenda: To consider and approve the unaudited results of the company for the three months ended 31 March 2015 and to approve the announcement of such unaudited quarterly results to be published on the website of the Growth Enterprise Market of the Stock Exchange and the company's designated website; to consider the payment of interim dividends, if any; to consider the closure of the register of members of the Company, if necessary; and to transact any other businesses.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
8058:HK $17.08 HKD -0.20

8058 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 8058.
View Industry Companies
 

Industry Analysis

8058

Industry Average

Valuation 8058 Industry Range
Price/Earnings 19.6x
Price/Sales 2.9x
Price/Book 3.6x
Price/Cash Flow 19.6x
TEV/Sales 2.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHANDONG LUOXIN PHARMACEUT-H, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.